Mejàre-Berggren Hanna, Olsson Christian
Department of Molecular Medicine and Surgery, Cardiovascular Surgery Unit, The Karolinska Institute and Karolinska University Hospital, Stockholm, Sweden.
Department of Molecular Medicine and Surgery, Cardiovascular Surgery Unit, The Karolinska Institute and Karolinska University Hospital, Stockholm, Sweden.
Ann Thorac Surg. 2017 Nov;104(5):1577-1582. doi: 10.1016/j.athoracsur.2017.05.010. Epub 2017 Jul 24.
The novel Leipzig-Halifax (LH) scorecard for acute aortic dissection type A (AADA) stratifies risk of in-hospital death based on age, malperfusion syndromes, critical preoperative state, and coronary disease. The study aim was to externally validate the LH scorecard performance and, if adequate, propose adjustments.
All consecutive AADA patients operated on from 1996 to 2016 (n = 509) were included to generate an external validation cohort. Variables related to in-hospital death were analyzed using univariable and multivariable analysis. The LH scorecard was applied to the validation cohort, compared with the original study, and variable selection was adjusted using validation measures for discrimination and calibration.
In-hospital mortality rate was 17.7% (LH cohort 18.7%). Critical preoperative state and Penn class non-Aa were independent predictors (odds ratio [OR] 2.42 and 2.45, respectively) of in-hospital death. The LH scorecard was adjusted to include Penn class non-Aa, critical preoperative state, and coronary disease. Assessing discrimination, area under receiver operator characteristic curve for the LH scorecard was 0.61 versus 0.66 for the new scorecard (p = 0.086). In-hospital mortality rates in low-, medium-, and high-risk groups were 14%, 15%, and 48%, respectively (LH scorecard) versus 11%, 23%, and 43%, respectively (new scorecard), and goodness-of-fit p value was 0.01 versus 0.86, indicating better calibration by the new scorecard. A lower Akaike information criterion value, 464 versus 448, favored the new scorecard.
Through adjustment of the LH scorecard after external validation, prognostic performance improved. Further validated, the LH scorecard could be a valuable risk prediction tool.
用于急性A型主动脉夹层(AADA)的新型莱比锡 - 哈利法克斯(LH)记分卡基于年龄、灌注不良综合征、术前危急状态和冠心病对住院死亡风险进行分层。本研究旨在对外验证LH记分卡的性能,若性能良好,则提出调整建议。
纳入1996年至2016年期间连续接受手术的所有AADA患者(n = 509)以建立外部验证队列。使用单变量和多变量分析来分析与住院死亡相关的变量。将LH记分卡应用于验证队列,与原始研究进行比较,并使用区分度和校准的验证方法对变量选择进行调整。
住院死亡率为17.7%(LH队列18.7%)。术前危急状态和Penn分级非Aa是住院死亡的独立预测因素(优势比[OR]分别为2.42和2.45)。LH记分卡经调整后纳入了Penn分级非Aa、术前危急状态和冠心病。评估区分度时,LH记分卡的受试者操作特征曲线下面积为0.61,新记分卡为0.66(p = 0.086)。低、中、高风险组的住院死亡率分别为14%、15%和48%(LH记分卡),分别对应11%、23%和43%(新记分卡),拟合优度p值分别为0.01和0.86,表明新记分卡校准性更好。较低的赤池信息准则值,464对448,支持新记分卡。
通过外部验证后对LH记分卡进行调整,其预后性能得到改善。经进一步验证后,LH记分卡可能成为一种有价值的风险预测工具。